Neutrophil chemotaxis plays an important role in the inflammatory response and when excessive or persistent may augment tissue damage. The effects of inhibitors indicated the involvement of one or more serine proteinases in human neutrophil migration and shape change in response to a chemoattractant. Monospecific antibodies, chloromethylketone inhibitors, and reactive-site mutants of -antitrypsin and -antichymotrypsin were used to probe the specificity of the proteinases involved in chemotaxis. Antibodies specific for cathepsin G inhibited chemotaxis. Moreover, rapid inhibitors of cathepsin G and -chymotrypsin suppressed neutrophil chemotaxis to the chemoattractants N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLP) and zymosan-activated serum in multiple blind well assays and to fMLP in migration assays under agarose. The concentrations of antichymotrypsin mutants that reduced chemotaxis by 50% would inactivate free cathepsin G with a half-life of 1.5-3 s, whereas the concentrations of chloromethylketones required to produce a similar inhibition of chemotaxis would inactivate cathepsin G with a half-life of 345 s. These data suggest different modes of action for these two classes of inhibitors. Indeed the chloromethylketone inhibitors of cathepsin G (Z-Gly-Leu-Phe-CMK) and to a lesser extent of chymotrypsin (Cbz-Gly-Gly-Phe-CMK) mediated their effect by preventing a shape change in the purified neutrophils exposed to fMLP. Antichymotrypsin did not affect shape change in response to fMLP even at concentrations that were able to reduce neutrophil chemotaxis by 50%. These results support the involvement of cell surface proteinases in the control of cell migration and show that antichymotrypsin and chloromethylketones have differing modes of action. This opens the possibility for the rational design of anti-inflammatory agents targeted at neutrophil membrane enzymes.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				T. Manolov, T. T. Tan, A. Forsgren, and K. Riesbeck Moraxella-Dependent {alpha}1-Antichymotrypsin Neutralization: A Unique Virulence Mechanism Am. J. Respir. Cell Mol. Biol., May 1, 2008; 38(5): 609 - 617. [Abstract] [Full Text] [PDF]

				A. J. Horvath, J. A. Irving, J. Rossjohn, R. H. Law, S. P. Bottomley, N. S. Quinsey, R. N. Pike, P. B. Coughlin, and J. C. Whisstock The Murine Orthologue of Human Antichymotrypsin: A STRUCTURAL PARADIGM FOR CLADE A3 SERPINS J. Biol. Chem., December 30, 2005; 280(52): 43168 - 43178. [Abstract] [Full Text] [PDF]

				B. Korkmaz, P. Poutrain, E. Hazouard, M. de Monte, S. Attucci, and F. L. Gauthier Competition between Elastase and Related Proteases from Human Neutrophil for Binding to {alpha}1-Protease Inhibitor Am. J. Respir. Cell Mol. Biol., June 1, 2005; 32(6): 553 - 559. [Abstract] [Full Text] [PDF]

				J. H. Kim, S. Y. Lee, S. M. Bak, I. B. Suh, S. Y. Lee, C. Shin, J. J. Shim, K. H. In, K. H. Kang, and S. H. Yoo Effects of matrix metalloproteinase inhibitor on LPS-induced goblet cell metaplasia Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L127 - L133. [Abstract] [Full Text] [PDF]

				American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 818 - 900. [Full Text] [PDF]

				R Mahadeva, L Sharples, R I Ross-Russell, A K Webb, D Bilton, and D A Lomas Association of {alpha}1-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis Thorax, January 1, 2001; 56(1): 53 - 58. [Abstract] [Full Text]

				A. M. Cole, J. Shi, A. Ceccarelli, Y.-H. Kim, A. Park, and T. Ganz Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds Blood, January 1, 2001; 97(1): 297 - 304. [Abstract] [Full Text] [PDF]

				R. Dhami, B. Gilks, C. Xie, K. Zay, J. L. Wright, and A. Churg Acute Cigarette Smoke-Induced Connective Tissue Breakdown Is Mediated by Neutrophils and Prevented by alpha 1-Antitrypsin Am. J. Respir. Cell Mol. Biol., February 1, 2000; 22(2): 244 - 252. [Abstract] [Full Text]

				R. A. Stockley New Approaches to the Management of COPD Chest, February 1, 2000; 117(2_suppl): 58S - 62S. [Abstract] [Full Text] [PDF]

				B. Gooptu, B. Hazes, W.-S. W. Chang, T. R. Dafforn, R. W. Carrell, R. J. Read, and D. A. Lomas Inactive conformation of the serpin alpha 1-antichymotrypsin indicates two-stage insertion of the reactive loop: Implications for inhibitory function and conformational disease PNAS, January 4, 2000; 97(1): 67 - 72. [Abstract] [Full Text] [PDF]

				D. M. MacIvor, S. D. Shapiro, C. T.N. Pham, A. Belaaouaj, S. N. Abraham, and T. J. Ley Normal Neutrophil Function in Cathepsin G-Deficient Mice Blood, December 15, 1999; 94(12): 4282 - 4293. [Abstract] [Full Text] [PDF]

				S. Rehault, M. Brillard-Bourdet, M. A. Juliano, L. Juliano, F. Gauthier, and T. Moreau New, Sensitive Fluorogenic Substrates for Human Cathepsin G Based on the Sequence of Serpin-reactive Site Loops J. Biol. Chem., May 14, 1999; 274(20): 13810 - 13817. [Abstract] [Full Text] [PDF]

				W.-S. W. Chang and D. A. Lomas Latent alpha 1-Antichymotrypsin. A MOLECULAR EXPLANATION FOR THE INACTIVATION OF alpha 1-ANTICHYMOTRYPSIN IN CHRONIC BRONCHITIS AND EMPHYSEMA J. Biol. Chem., February 6, 1998; 273(6): 3695 - 3701. [Abstract] [Full Text] [PDF]